Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Masked, Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of Meibomian Gland Dysfunction in Patients With Demodex Lid Infestation

NCT05454956 is registered in ClinicalTrials.gov with Tarsus Pharmaceuticals, Inc. as lead sponsor.

NCT NCT05454956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05454956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Masked, Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of Meibomian Gland Dysfunction in Patients With Demodex Lid Infestation
Lead sponsor
Tarsus Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Completed
Start date
August 3, 2022
Completion date
May 18, 2023
Enrollment
39 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

blepharitis, demodex infestation, meibomian gland dysfunction